Triple negative breast cancer (TNBC) is characterized by the absence of estrogen receptor (ER), progesterone receptor (PgR) and human epidermal growth factor receptor 2 (HER2), accounting for 15–20% of all breast cancers [1]. The gene discussed is PGR; the disease is breast carcinoma.